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Background: Surfactant abnormalities have been implicated in reperfusion injury
and respiratory failure in lung transplantation.
Methods: We investigated the efficacy of bronchoscopic administration of a bovine
natural lung surfactant extract (Alveofact) to improve gas exchange and lung
mechanics after heterologous left lung transplantation in foxhounds (4°C ischemia
for 24 hours, conservation with Euro-Collins solution). Animals received either no
surfactant therapy (untreated controls, n  6) or 50 mg/kg body weight (prior to
explantation, only graft) and 200 mg/kg body weight Alveofact (immediately after
reperfusion, both lungs, n  6). After lung transplantation, separate but synchro-
nized ventilation of each lung was performed in a volume-controlled, pressure-
limited mode for 12 hours, with the animals prone. Small catheters were inserted
into the pulmonary veins of both the graft and the recipient’s native lung for separate
blood gas analysis. In the control group, marked protein leakage, influx of neutro-
phils into the alveolar space, and pulmonary edema formation (extravascular lung
water; wet/dry ratio) were encountered in the transplanted lung but only to a very
minor extent in the recipient’s native lung.
Results: Lung compliance values and arterial oxygenation progressively deterio-
rated in the transplanted but not in the native lungs. Pulmonary hemodynamics did
not change significantly. Surfactant administration did not significantly influence the
development of reperfusion edema, protein leakage, and neutrophil influx into the
grafts. However, surfactant restored the surface activity and the gas exchange
(PaO2/FIO2 of 201.2  20.2 mm Hg vs 119.8  21.7 mm Hg in controls; P  .05) in
the transplanted lungs, and compliance was markedly improved in the surfactant-treated
animals (18.8  1.8 mL/mbar vs 11.5  1.6 mL/mbar in the controls; P  .05).
Conclusion: Bronchoscopic surfactant administration does not prevent leukocyte
influx or vascular leakage but does protect against respiratory failure and improves
lung mechanics in single lung transplantation in dogs.
Pulmonary edema formation with progressive worsening of gas ex-change and lung mechanics, commonly referred to as “ischemia-reperfusion injury,” is a frequent and feared complication in lungtransplantation.1 The pathophysiological abnormalities encounteredunder these conditions resemble typical features of the adult respira-tory distress syndrome (ARDS) and include a high alveolar protein
and fluid burden, a pronounced influx of inflammatory cells (mostly neutrophils)
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into the alveolar compartment, and increased local and
systemic levels of proinflammatory cytokines (tumor necro-
sis factor-alpha, interleukin-6, interleukin-8).
Transbronchial surfactant administration has been shown
to improve gas exchange in a large body of experimental
ARDS models and in patients suffering from severe ARDS.2
In view of the similarities between reperfusion injury and
ARDS, it has been speculated that changes in the function of
the pulmonary surfactant system might also be operative
under conditions of pulmonary ischemia-reperfusion. Sur-
factant administration after lung transplantation was firstly
suggested by Novick and colleagues3 in 1991. During the
following years a considerable number of experimental
studies have been published to verify the benefit of surfac-
tant treatment in reperfusion injury. Natural surfactant prep-
arations were used in different animal models such as ca-
nine, minipigs, and rats.4-9
A detailed analysis of the biochemical and biophysical
surfactant properties in canine lungs undergoing 24 hours of
cold ischemia and 12 hours of reperfusion was undertaken
and the occurrence of severe surfactant abnormalities in the
reperfusion period was demonstrated, as reported in the
companion article.9a The studies were performed under
conditions of separate but synchronized ventilation of the
transplanted (single) lung and the native lung to avoid tidal
volume shift between the graft and the native lung, which
may otherwise give way to the appearance of ventilator-
induced lung injury (VILI).10 We report on the impact of
bronchoscopic surfactant administration on the develop-
ment of posttransplantation lung injury. This maneuver was
found to not affect pulmonary edema formation and neu-
trophil influx into the alveolar space but it strongly antag-
onized the loss of compliance and the deterioration of gas
exchange in the transplanted lungs. Administration of sur-
factant to lungs subjected to severe ischemia-reperfusion
may thus be suggested as a useful therapeutic regimen to
improve posttransplantation lung function.
Methods
Materials and Methods
Calf lung surfactant extract (Alveofact) was a generous gift from
Dr H. Weller (Thomae, Biberach, Germany); this material is
widely used for infant respiratory distress syndrome (IRDS) treat-
ment and has also been investigated in a pilot study for treatment
of ARDS. Euro-Collins solution was a generous gift from Frese-
nius, Bad Homburg, Germany. Anesthesia was induced by injec-
tion of thiopentone (Altana Pharma, Konstanz, Germany), fentanyl
(Curamed Pharma GmbH, Karlsruhe, Germany), and rocuronium
(Organon Teknika, Boxtel, NL) and was maintained by a contin-
uous infusion of midazolam hydrochloride (Hoffmann LaRoche
AG, Grenzach Wyhlen, Switzerland). Flolan (100 g/L; Well-
come, Greenford, UK) was added to the Euro-Collins solution.
Transplantation Model
Heterologous left lung transplantation was performed in fox-
hounds (12 donors, 12 recipients, both sexes, 27-33 kg, weight-
matched) with the approval of the local authorities. The animals
were randomly assigned to the control group (n  6) and the
surfactant group (n  6). The animals received full care according
to the Principles of Laboratory Animal Care (National Institutes of
Health publication no. 85-23, revised 1985) and were allowed
water and food ad libitum until 12 hours prior to surgery. None of
the animals showed any signs of infection, as based on body
temperature, peripheral blood counts, and lung auscultation. All
experimental and surgical approaches were performed under ster-
ile conditions by 1 cardiothoracic surgeon. The animals did not
develop fever, and blood cultures obtained at 6 and 12 hours
postreperfusion were all sterile. All animals remained hemody-
namically stable; there was no need for catecholamine administra-
tion during surgery or the postoperative course. Volume (Ringer’s
lactate) was substituted depending on central venous (8 mm Hg)
and mean arterial (60 mm Hg) pressures. There was no differ-
ence in warm ischemic time between the groups (Table 1).
Ventilation Patterns
After reperfusion both lungs were independently ventilated using 2
Evita II ventilators (Dra¨ger, Lu¨beck, Germany) in a master and
slave mode. Two tracheal tubes (both 9-mm internal diameter)
were inserted, 1 into the left and 1 into the right main bronchus,
and the left bronchus was snared tightly around the tracheal tube.
The tube placed to the right bronchus had its balloon cuff inflated
near the tracheal bifurcation (while it was avoided) to cover the
ostium of the upper lobe bronchus. The right lung received 60%
and the left lung 40% of the entire tidal volume, which was started
with 14 mL/kg body weight (BW) and then adjusted to maintain
normocapnia in lung veins to either side, and was then left un-
changed for the remainder of the experiment. Ventilator frequency
TABLE 1. Warm, cold, and total ischemic time of the transplanted lungs
Warm ischemic time
(minutes)
Cold ischemic time
(minutes)
Total ischemic time
(minutes)
Control (n  6) 54.3 8.2 1436.7 59.2 1487.0 58.1
Surfactant (n  6) 50.3 3.3* 1443.3 60.3† 1497.7 60.9‡
Given are the mean SEM of the warm ischemic time (preparation and implantation), the cold ischemic time (flush preservation until take out of the sterile
bag), and the total ischemic time (sum of both). Statistical niveau between control (not treated) and surfactant (surfactant treatment) as stated in the table.
*P  .44.
†P  .94.
‡P  .90.
General Thoracic Surgery Friedrich et al
336 The Journal of Thoracic and Cardiovascular Surgery ● February 2004
G
TS
was set to 10/min, an upper pressure limit of 30 mm Hg, FIO2 of
0.5, and positive end-expiratory pressure (PEEP) of 5 cm H2O for
the duration of the experiment. Under these conditions, normocap-
nia was obtained.
Donor Procedure
After intravenous anesthesia with thiopentone (30 mg/kg BW) and
oropharyngeal intubation, the animals were ventilated at a fre-
quency of 10/min, with an FIO2 of 0.5, in a volume-controlled
(tidal volume 14 mL/kg BW), pressure-limited (pmax  30 mm
Hg) fashion (Evita II, Dra¨ger). Tidal volume was adjusted to
maintain paCO2 values between 35 and 40 mm Hg. Anesthesia was
maintained with fentanyl (0.7 mg/h), midazolam (5 mg/h), and
rocuronium (15 mg/h) via continuous infusion, and an extra
1.5-mg dose of fentanyl was administered for thoracotomy. Left
lateral thoracotomy was performed through the fifth intercostal
space. After the pericardium was opened and the great vessels
were dissected, a large-bore line was inserted into the pulmonary
artery. In the surfactant group, 50 mg/kg BW Alveofact was
instilled by bronchoscopic technique in 10 divided doses into each
segment of the left lung. No transbronchial fluid administration
was performed in the control group. Immediately after opening of
the left atrial appendage, 60 mL/kg of cold, modified Euro-Collins
solution (including 100 g/L prostaglandin E2) were infused
through the pulmonary arterial line at a temperature of 4°C and
under a pressure of 30 cm H2O. The lungs were ventilated through-
out the preservation period. At the end of the washout procedure,
the lungs were inflated to a pressure of 20 cm H2O and the trachea
was stapled. The heart-lung block was then excised, packed into
sterile bags, and stored swimming in 4°C water in a refrigerator for
24 hours.
Recipient Procedure
Anesthesia and ventilation were identical as described for the
donors, as was left lateral thoracotomy. The left-sided lung vessels
were dissected and right lung ventilation was established; the
pulmonary artery was clamped with a bulldog clamp and the
bronchus with an atraumatic clamp. After heparinization (50 U/kg
BW) a Cooley clamp was positioned to truncate the pulmonary
veins at the level of the left atrium, cutting the tissue bridge to
create an opening for the left atrial cuff anastomosis of the donor
lung. The donor heart-lung block was taken from the storage bag,
and the left lung was prepared with a remainder of left atrial cuff
containing the left pulmonary veins. Implantation sequence was
left atrial cuff with 7-0 Prolene suture (Ethicon, Norderstedt,
Germany), left bronchus anastomosis with 4-0 Cardiofil (Braun-
Dexon, Tuttlingen, Germany) running suture, and the left pulmo-
nary artery with 7-0 running Prolene suture. Total time from the
end of cold ischemia period until reperfusion was identical for both
groups (Table 1). The preserved and stored but not transplanted
right donor lung was lavaged ex situ to assess storage-induced
changes. After completion of left lung transplantation, a second
tracheal tube (9 mm internal diameter) was positioned in the left
main bronchus of the graft and secured tightly, thus allowing
separate ventilation of the graft and the native lung as previously
described. Upon ventilation of the graft, reperfusion was started
and time was set to zero. Next, 2 small catheters were placed into
the pulmonary veins of the left and the right lower lobes for
withdrawal of blood samples. After insertion of a chest tube and
wound closure, the animals were positioned on a vacuum-mattress
and remained in the prone position until the end of the observation
period (12 hours).
In the surfactant group, a second dose (200 mg/kg BW) of
Alveofact was administered bronchoscopically in divided doses
into each segment of both lungs, as soon as the animals were in the
prone position. No transbronchial administration of fluids was
performed in the control group. The animals were sacrificed by
exsanguination. Both lungs were excised and samples for wet-to-
dry ratio were taken from the left and right lower lobe.
Lung Function
Central venous, arterial, and left and right pulmonary venous blood
samples were withdrawn hourly to determine hemoglobin, potas-
sium, and blood gases (blood gas analyzer ABL 4, Radiometer,
Copenhagen, Denmark). Similarly, dynamic compliance, mean
and peak ventilation pressures, as well as tidal and minute volume
were read from the respirator once an hour.
Hemodynamic Monitoring
A femoral artery and a pulmonary artery catheter (Swan Ganz,
Baxter Healthcare, Irvine, Calif) for characterization of pulmonary
and systemic hemodynamics and blood sampling were placed
percutaneously; pressure transducers (Millar Micro Tip, Millar
Instruments Inc, Houston, Tex) were positioned at mid-heart level
and referenced to the atmospheric pressure level to record mean
arterial pressure, mean pulmonary arterial pressure, central venous
pressure (CVP), and pulmonary capillary wedge pressure (PCWP).
Using a Sirecust 9000 Monitor (Siemens Medical Products, Erlan-
gen, Germany), cardiac output was assessed by thermodilution.
Cardiac index (CI), pulmonary vascular resistance index, and
systemic vascular resistance index were calculated by standard
formula. The body surface area (BSA) was estimated as follows:
BSA (m2)  (0.1 · (kg body weight)2/3).
Measurement of Pulmonary Fluid Accumulation
Two different techniques were employed. (1) The wet-to-dry ratio
was determined on all excised lungs. Three lung slices, all ob-
tained from the upper lobe, were weighed immediately after har-
vesting and after reaching complete dryness (65°C for 14 days). (2)
Extravascular lung water (EVLW) was determined by means of a
thermo-dye dilution technique (COLD Z-0-21 Monitor, Pulsion
Medical Systems, Munich, Germany).11 For this purpose, an ad-
ditional arterial thermistor-tipped fiberoptic catheter (Pulsiocath
4F FT PV 2024, Pulsion Medical Systems) was inserted into the
femoral artery. CI, extravascular lung water index (EVLWI), and
intrathoracic blood volume index (ITBVI) were determined in
triplicate by injecting 8 mL of ice-cooled indocyanine green (ICG;
1 mg/mL; Pulsion Medical Systems) via the central venous line.
With the thermo-dye dilution technique, ITBV and EVLW were
calculated as: ITBVI  CI · MTtICG, where MTtICG is the mean
transit time of indocyanine green, and EVLWI (CI · MTtherm)
ITBV, where MTtherm is the mean thermal transit time. EVLWI
was assessed at baseline (induction of anesthesia) and 1, 3, 6, 9,
and 12 hours after reperfusion.
Bronchoalveolar Lavage
Bronchoalveolar lavage fluid (BALF) was collected either in vivo
by flexible bronchoscopy (Olympus BF P-10 bronchoscope,
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Olympus, Hamburg, Germany) after 6 hours of reperfusion or in
vitro by whole lung lavage excluding the upper lobes. In case of
bronchoscopic lavage, the instrument was placed in wedge posi-
tion in the upper lobe and the lavage was performed by repetitive
injection and gentle aspiration of ten 20-mL aliquots of sterile
saline solution (recovery 60%). For whole lung lavage, the main
bronchus of the lower lobe was cannulated and fixed by a trans-
bronchial suture, and lavage was done with 500 mL of sterile
saline solution (recovery  70%) by passive pressure gradients of
40 cm H2O. The lavage fluids were then filtered through sterile
gauze, collected on ice, and immediately centrifuged at 200g (4°C,
10 minutes) to separate cellular material. Protein content of this
cell-free BALF was measured using a commercially available kit
based on bicinchoninic acid.12 The remaining supernatant was
aliquoted, frozen in liquid nitrogen, and stored at 85°C until
subsequent measurements.
Statistics
All results are reported as means  standard error of the mean
(SEM) and were analyzed by a biostatistician (Moredata GmbH,
Giessen, Germany). Statistical analysis of differences between
surfactant-treated lungs and controls was performed by testing
principle significant diversity first (Kruskal-Wallis H test), fol-
lowed by comparison with a nonparameteric test (Mann-Whitney
U test). A Wilcoxon matched-pair test was used to compare
baseline values with each time point.
Results
Storage of the Euro-Collins flushed lungs at 4°C for 24
hours did not result in a statistically significant rise of
lavage protein or neutrophil contents, even if the protein
levels were increased to a certain extent (Table 2). Simi-
larly, the analysis of the wet-to-dry ratio did not detect
significant lung fluid accumulation at the end of the pres-
ervation period (Figure 1, top). In contrast, after transplan-
tation and reperfusion, a pronounced increase in pulmonary
edema accumulation, lavage protein content, and the per-
centage of neutrophils within the alveolar cell population
was noted (Table 2). This was evident both for the 6-hour
and the 12-hour reperfusion period in the grafted lung. To
some minor extent, however, protein leakage, neutrophil
influx, and weight gain were also detected in the recipient’s
native lung. The percentage of neutrophils increased to
82.0%  7.3% (mean  SEM) in the graft and to 30.0% 
6.7% in the native lungs within 12 hours of reperfusion, as
compared with 5% in controls. BALF protein levels were
increased approximately fourfold in the graft and approxi-
mately twofold in the recipient’s native lung 12 hour after
onset of reperfusion (Table 2).
In the graft, the wet-to-dry ratio at the end of the reper-
fusion period (12 hours) was approximately doubled, and an
approximately 1.7-fold increase in the wet-to-dry ratio was
encountered in the native lungs (Figure 1, top). When ap-
plying the thermal dye dilution technique for characteriza-
tion of the extravascular pulmonary content, a doubling of
lung fluid was again noted in the transplanted and in the
native lungs (Figure 1, bottom).
In parallel, the transplanted lungs developed a progres-
sive decline of gas exchange and mechanical properties
TABLE 2. BALF protein content and neutrophil counts
Baseline Postischemia
Postreperfusion
6 hours 12 hours
BALF protein (g/mL)
Standard treatment
Graft 476.9 59.4 1443.6 720.20* 1895.6 187.1†
Native lung 240.5 34.9 153.8 32.7 501.9 167.7
Surfactant treatment
Graft 393.7 97.8 844.0 269.0 1637.0 253.0†
Native lung 290.0 68.7 188.5 32.3 447.4 123.1
PMN in BALF (%)
Standard treatment
Graft 1.8 0.6 25.5 14.6 82.0 7.3†
Native lung 1.8 0.7 28.8 4.3† 30.0 6.7§
Surfactant treatment
Graft 6.3 3.2 36.0 15.1‡ 84.0 6.4†
Native lung 2.0 0.8 13.3 14.4 23.0 13.8
BALF, Bronchoalveolar lavage fluid; PMN, polymorphonuclear neutrophils.
Given are the mean SEM of the BALF protein concentration (in g/mL) and the neutrophil percentage (given in percentage of all cells, n 6 lungs each).
Baseline values were obtained from the excised left recipient lungs. Postischemia data originate from the donor right lungs, undergoing preservation but
not transplantation. All other data refer to either the transplanted left lungs (graft) or the native recipient right lungs (native).
*P  .05 in comparison to baseline values.
§P  .01 in comparison to baseline values.
†P  .001 in comparison to baseline values.
‡P  .08 in comparison to baseline values.
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under conditions of separate but synchronized mechanical
ventilation. PaO2/FIO2 values (determined at an FIO2 of 0.5
after reperfusion) were 629.3 11.9 mm Hg under baseline
conditions, 253.5  15.1 mm Hg at the onset of the reper-
fusion period, and dropped to 121.7  25.6 mm Hg (6
hours) and 119.8  21.7 mm Hg (12 hours) in the trans-
planted lungs (Figure 2). The graft’s compliance was 19.5
 1.6 mL/mbar after 1 hour of reperfusion and thus signif-
icantly reduced as compared with baseline conditions (40.2
 5.8 mL/mbar), with a further decline to 11.5  1.6
mL/mbar at the end of the 12-hour reperfusion period (Fig-
ure 3). In contrast to the graft, gas exchange and compliance
of the recipient’s native lung did not significantly decrease
over this time span. However, as compared with the above-
mentioned baseline data, compliance values of the recipi-
ent’s native lung were somewhat lower (27 mL/mbar)
throughout the postoperative period. This was also true for
the gas exchange conditions, in particular in the early post-
operative phase, with subsequent gradual increase in the
PaO2 values, which nearly approached baseline data at the
end of the 12-hour observation period.
All 6 recipients of the control group were hemodynam-
ically stable, not requiring any catecholamine support. As
given in Table 3, CVP and PCWP did not change signifi-
cantly. After reperfusion, a significant decrease in mean
arterial pressure compared with baseline and compared with
the surfactant-treated group was found in the control group
(Table 3). In parallel, a less pronounced increase in CI
compared with baseline values was detectable in both the
control and surfactant group (Table 3). However, the de-
Figure 1. Wet-to-dry ratios (top) and extravascular lung water
(bottom) in the time course of single lung transplantation. Wet-
to-dry ratios of the untreated left recipient lungs (baseline, orig-
inating from animals assigned to either the control or the surfac-
tant group), the nontransplanted but Euro-Collins–preserved right
donor lung (preserved, assessed at the end of the preservation
period), the recipient right native lung (native lung, assessed 12
hours after transplantation), and the transplanted left lung (graft,
assessed 12 hours after reperfusion) are given. Values are indi-
cated for the control group (untreated, black column) and the
surfactant-treated group (treated, gray column). Extravascular
lung water (EVLW) was determined pre– and post–single lung
transplantation in animals with (surfactant) or without (control)
surfactant administration. n.s., not significant. Mean  SEM of 6
experiments.
Figure 2. PaO2/FIO2 values in the pulmonary venous samples of the
transplanted lung (graft, open sqaure) and the recipient’s native
lung (native, open circle). Data originate from animals receiving
(treated, closed circle, closed square) or not receiving (untreated,
open circle, open square) surfactant administration (mean SEM
of 6 lungs each). Significance level is indicated by P < .05,
P < .01, or P < .001 for comparison between control
group and surfactant group.
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crease in systemic vascular resistance did not reach statis-
tical significance (data not shown). The pulmonary arterial
pressure and the transpulmonary gradient displayed signif-
icant higher values compared with baseline in the control
group, but this did not reach statistical significance com-
pared with the surfactant group (Table 3).
The bronchoscopic instillation of a bovine surfactant
extract to the graft prior to ischemia (total dose 50 mg/kg
BW) and to both the graft and the native lung upon start of
reperfusion (total dose 200 mg/kg BW) resulted in a marked
improvement of gas exchange and compliance in the trans-
planted lungs (Figures 2 and 3). After completion of the
second surfactant administration, the compliance data of the
graft were 23.0  0.5 mL/mbar, surpassing those in the
non-surfactant–treated grafts. Moreover, stability of the
compliance values of the grafts undergoing surfactant ad-
ministration was noted over the subsequent 12-hour reper-
fusion period, a feature significantly different from the
control grafts. The PaO2/FIO2 values of the surfactant-treated
grafts were 629.3 11.9 mm Hg at the beginning and 201.2
 20.2 mm Hg at the end of the reperfusion period, thus
significantly surpassing the PaO2/FIO2 data of the nontreated
transplanted controls. In contrast, the surfactant administra-
tion did not affect the pulmonary fluid accumulation (Figure
1, top and bottom), the neutrophil influx into the alveolar
space, and the protein leakage into this compartment (Table
2).
Discussion
When analyzing the results of the current study, several
aspects have to be discussed.
Model Considerations
In general, the presently used left lung transplantation
model in dogs followed established techniques in the
field.5,7,13,14 However, some important modifications were
undertaken and comprised: first, the separate but synchro-
nized ventilation of the graft and the native lung by using 2
ventilators working in the master/slave mode; second, the
insertion of small catheters into the pulmonary veins of both
lungs to obtain blood samples from each lung for blood gas
analysis; and third, an immediate turn of the animals to the
prone position upon termination of the surgical procedures.
Such experimental setting ascertained (1) full control over
volume and pressure applied to each lung, and, by this, (2)
prevention of any gas volume shift between graft and native
lung, (3) avoidance of clamping procedures of the large
pulmonary arteries, and (4) restoration of physiological
gravity forces on ventilation and perfusion distribution
(prone position).
Influence of Surfactant Administration on Pulmonary
and Systemic Hemodynamics
As anticipated from clinical15 and experimental16 data, a
modest increase in pulmonary artery pressure and pulmo-
nary vascular resistance was encountered in this single lung
transplant model. This increase was not influenced by the
surfactant treatment. This is in line with the previous ob-
servation that surfactant replacement improved gas ex-
change but did not affect pulmonary hemodynamics in
patients with severe ARDS.2 Interestingly, however, the
decline in systemic arterial pressure and vascular resistance,
consistently noted in all transplanted animals, was only very
transient and in the further course fully absent under con-
ditions of surfactant administration. The underlying reasons
for this phenomenon deserve further clarification.
Influence of Surfactant Administration on Neutrophil
Recruitment, Protein Leakage, and Pulmonary Edema
Formation
Lung surfactant has been implicated in the regulation of
alveolar fluid homeostasis and both natural surfactant prep-
arations, and single surfactant compounds were reported to
suppress inflammatory activities of immunocompetent cells,
Figure 3. Dynamic lung compliance in animals undergoing single
lung transplantation, analyzed separately for the transplanted
lung (graft, open square) and the recipient’s native lung (native,
open circle). Data originate from animals receiving (treated,
closed circle, closed square) or not receiving (untreated, open
circle, open square) surfactant administration (mean  SEM of 6
lungs each). Significance level is indicated byP < .05,P <
.01, or P < .001) for comparison between control group and
surfactant group.
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including free radical production by alveolar macrophages
and monocytes, macrophage migration, and lymphocyte
proliferation.17,18 However, in the present study, edema
formation, protein leakage into the alveolar space, and neu-
trophil migration into this compartment were not signifi-
cantly affected by bronchoscopic surfactant administration,
though this approach established near-physiological surfac-
tant function in the transplanted lungs. This is in line with a
previous study of Novick and colleagues,5 in which surfac-
tant instillation prior to ischemia alone or in combination
with surfactant instillation after reperfusion caused only
very minor (nonsignificant) reduction of reperfusion-related
protein leakage. In contrast to the surfactant instillation
alone, after combined therapy with aerosolized and instilled
surfactant preparations the reduction in intra-alveolar pro-
tein content was more pronounced. Probably the technique
of treatment has an impact on the permeability for serum
proteins.13
Interestingly, neutrophil influx and plasma protein leak-
age also occurred to some very minor extent in the native
lungs of animals undergoing single lung transplantation. In
previous transplantation studies with combined lung venti-
lation,5,14,19 the increase in BALF protein levels in the
native lungs, observed after the reperfusion period, nearly
approximated that in the transplanted lungs, irregardless of
the length of the ischemia period (1.5-36 hours) or the mode
of ischemia (warm vs cold). It is tempting to speculate that
the prevention of hyperinflation of the native lungs due to
the mode of separate lung ventilation was the predominant
underlying reason for the maintenance of near-physiological
function including barrier properties in the native lungs in
the present study.
Improvement of Mechanics and Gas Exchange after
Bronchoscopic Surfactant Administration
A progressive impairment in gas exchange and loss of lung
compliance were noticed in the graft, but not in the recipi-
ent’s native lung. In accordance with previous investiga-
tions in the field, changes in surface activity and gas ex-
change were tightly linked, as suggested by the highly
significant correlation between minimum surface tension
and PaO2 in the transplanted lungs (see Figure 4).
As could have been anticipated on the basis of these data,
both the compliance values and the gas exchange data of the
transplanted lungs were markedly improved under condi-
tions of bronchoscopic surfactant administration. This find-
ing supports previous investigations, which similarly
showed a beneficial impact of surfactant on arterial oxygen-
TABLE 3. Hemodynamic variables in the animals undergoing lung transplantation
Baseline 5 minutes 1 hour 3 hours 6 hours 9 hours 12 hours
CI con.
(L/min)
2.2 0.1 3.3 0.3 3.6 0.4 2.9 0.0 2.9 0.1 2.9 0.3 3.1 0.2
CI surf.
(L/min)
2.3 0.1 2.8 0.3 2.7 0.2 3.0 0.2 2.9 0.1 3.5 0.3 3.5 0.4
CVP con.
(mm Hg)
5.8 0.7 6.8 0.8 5.0 1.0 4.0 0.4 4.4 0.3 7.0 0.4 6.8 0.7
CVP surf.
(mm Hg)
6.3 1.1 5.7 1.1 6.3 1.4 5.5 1.2 5.8 1.7 6.5 0.6 6.7 0.9
PCWP con.
(mm Hg)
6.6 0.8 5.8 0.5 7.2 1.1 5.9 0.6 4.4 1.0 7.2 0.5 8.0 0.2
PCWP surf.
(mm Hg)
7.5 0.8 7.3 1.1 6.8 1.0 6.0 1.0 6.3 0.9 8.3 0.6 7.2 0.9
PAP con.
(mm Hg)
14.6 1.3 14.6 1.6 13.2 1.3 15.0 0.7 15.0 1.7 17.0 1.1 19.5 1.4
PAP surf.
(mm Hg)
15.5 2.1 15.8 1.2 15.8 2.5 17.8 0.7 17.7 1.5 20.7 1.0 22.0 1.6
MAP con.
(mm Hg)
72.2 3.0 78.3 3.8 67.8 3.5 66.5 1.3 70.8 3.6 70.3 1.8 64.6 2.5
MAP surf.
(mm Hg)
81.5 6.4 86.7 7.4 77.8 3.0 71.3 1.7 82.3 1.3† 85.8 4.3† 88.8 6.4*
TPG con.
(mm Hg)
8.0 0.5 8.8 0.7 8.0 0.6 9.5 0.7 11.0 0.7 11.8 0.3 11.0 1.1
TPG surf.
(mm Hg)
9.0 0.7 7.2 0.7 6.7 0.6 11.2 0.7 11.2 0.5 12.3 0.9 12.0 1.0
CI, Cardiac index; con., control; surf., surfactant group; CVP, central venous pressure; PCWP, pulmonary capillary wedge pressure; PAP, pulmonary arterial
pressure; MAP, mean arterial pressure; TPG, transpulmonary pressure gradient (difference between mean pulmonary artery pressure and capillary wedge
pressure).
*P  .05, comparison between control and surfactant group.
†P  .01, comparison between control and surfactant group.
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ation in experimental lung transplantation.4,8,13,20 The
present study adds an important piece of knowledge to this
field because it shows that indeed such effect is due to a
direct impact of the exogenous surfactant material on the
reperfused lungs, which are ventilated in a controlled fash-
ion independent of the native lung. This observation does
not exclude the possibility that surfactant administration
might additionally influence the development of VILI in the
nontransplanted lung, which may occur under conditions of
combined ventilation and which was excluded by the cur-
rent experimental protocol. Such view is supported by the
data of Novick and coworkers,5 who observed marked im-
pairment of the native lung’s gas exchange in a canine
model of ischemia and reperfusion, as suggested by blood
gas analysis upon left pulmonary artery snaring14 or, indi-
rectly, blood gas data obtained from arterial source reflect-
ing both lungs. Noteworthy, the marked beneficial effect of
surfactant administration on compliance and gas exchange
in the transplanted lungs in the present study was noted
under prone positioning of the animals, which should pro-
vide the best possible physical conditions for ventilation-
perfusion matching, and under PEEP ventilation, employed
to prevent atelectasis formation. The currently applied total
dose of 250 mg surfactant per kilogram BW is well in line
with preceding studies of surfactant administration in
ARDS models and is based on the knowledge that surfactant
inhibitory mechanisms based on protein leakage and inflam-
matory mediator generation are to be overcome by the
exogenous surfactant material (see companion article9a).
With this dose being administered in part before onset of
ischemia (50 mg/kg) and in part immediately upon reper-
fusion (200 mg/kg), the dissociation of the PaO2 curves of
the surfactant-treated and the control grafts already com-
menced within 1 hour of reperfusion.
VILI of the Native Lung under Experimental
Conditions
Involvement of the native lung during reperfusion injury
(remote injury) is well known under clinical conditions and
is thought to be related to blood-borne mediators that are
released by the reperfused donor lung. In addition, most
entities being associated with the need for lung transplan-
tation (eg, idiopathic pulmonary fibrosis, cystic fibrosis) are
known for far-reaching alterations of the surfactant proper-
ties. In these cases, a donor lung originating from a healthy
donor and thus having good surface tensionreducing prop-
erties is transplanted into a patient who has a native lung
with increased alveolar surface tension. If ventilated jointly
after reperfusion, the donor might be preferentially venti-
lated due to its better compliance, and, if reperfusion injury
develops, surface tension properties might align and distri-
bution of minute ventilation might be similar between both
lungs. In experimental models of lung transplantation, how-
ever, matters might be significantly different. In this exper-
iment, a donor organ originating from a healthy lung but
being held under (mostly prolonged) ischemic conditions is
transplanted into a healthy recipient with a healthy con-
tralateral lung. This native lung, as again shown in the
companion article,9a must be expected to have good surface
tension–reducing properties. Due to the very good compli-
ance, this native organ might thus be very susceptible to the
deleterious effects of high tidal volume ventilation and thus
VILI, once reperfusion injury develops in the graft and if
jointly ventilated with the graft. It is in this line of reasoning
that in a model of experimental lung transplantation,14
marked changes of gas exchange, surface tension, and sur-
factant composition were noted early also in the native
organ. Actually, these authors did not find a difference in
PaO2 values between the transplanted organ versus the na-
tive lung. In another paper addressing also surfactant prop-
erties after single lung transplantation in dogs,7 it was found
that the small-to-large surfactant aggregate ratio was even
higher in the native lung as compared with the graft 6 hours
after reperfusion. In our present study, we were unable to
detect a relevant reduction in functional properties of the
Figure 4. Correlation of PaO2/FIO2 values with surface activity, as
assessed with the pulsating bubble surfactometer. Given are the
data pairs of the controls and the graft in absence of surfactant
therapy. BALF samples were taken from the control group prior
transplantation and 6 and 12 hours after reperfusion respectively.
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native lung under separate but synchronized ventilation.
Apart from an increase in extravasal water accumulation,
the loss of permeability was not extended and a significant
leakage of plasma proteins or a transmigration of neutro-
phils into the alveolar space did not occur.
VILI may substantially contribute to the severity of
ARDS, as suggested from a recent multicenter trial.21 In
fact, severe lung injury including neutrophil transmigration,
systemic and alveolar cytokine release, impairment of sur-
factant function, disturbance of gas exchange, and loss of
lung compliance may experimentally be provoked by ven-
tilating otherwise healthy lungs with inappropriately high
tidal volume.22 A further study of Novick and colleagues7
addressed the capability of bovine surfactant preparations to
improve the function of ventilator-injured donor lungs in
order to improve the donor pool. Otherwise healthy donor
lungs subjected to mechanical ventilation with high tidal
volumes showed decreased oxygen tension, increased intra-
alveolar protein content, and a significant deterioration of
the surfactant composition. After surfactant treatment a
restoration of lung function and surfactant properties could
be achieved.7 In view of these new insights into the impact
of respirator therapy on the progression of acute lung injury,
we employed separate but synchronized ventilation of the graft
and the native lung. By this, we think, we avoided volume shift
and thus hypoventilation of the transplanted organ graft on the
one hand and overinflation of the native lung on the other hand.
Moreover, this approach ascertained adequate assessment of
the gas exchange properties of each lung, with mismatch of
volume distribution between the 2 different organs in the single
lung–transplanted animals being prevented.
Conclusion
In concert with the finding that the ex vivo surfactant
properties are seriously impaired in the transplanted lungs
but not in the native recipient’s lungs (see companion
article9a), the beneficial effect of bronchoscopic surfactant
administration on arterial oxygenation and compliance of
the graft further supports the view that surfactant abnormal-
ities substantially contribute to the disturbances of gas ex-
change and the loss of compliance in reperfused lungs.
Surfactant administration, whether undertaken via bron-
choscopy as currently performed or via different delivery
techniques (instillation, aerosolization), thus presents a new
therapeutic approach for improving posttransplantation
graft function. Future studies should address the question
whether such surfactant administration is most appropri-
ately undertaken prior to ischemia, both prior to ischemia
and in the early postreperfusion period as presently per-
formed, or in a later phase of reperfusion injury.
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